NOS2: Nitric oxide synthase, inducible
Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body.
- Drugs that act on it: 2
- Approved: 0
- In phases 1 to 3: 2
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on NOS2, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Psoriasis0.55
- Psoriasis vulgaris0.46
- Psoriatic arthritis0.41
- Type 2 diabetes mellitus0.39
- Chronic atrophic gastritis0.35
- Skin disorder0.30
- Myocardial infarction0.28
- Acute myocardial infarction0.27
- Ankylosing spondylitis0.22
- Triple-negative breast carcinoma0.12
- Insulin resistance0.12
- Neoplasm0.12
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4481, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. Gene name, function (UniProt P35228, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets